Chemical Information
Antiviral agent ID	DrugRepV_4287
Antiviral agent name	4-{5-[2-(4-tert-butylphenyl)ethyl]-1,3,4-oxadiazol-2-yl}phenol
IUPAC Name	4-{5-[2-(4-tert-butylphenyl)ethyl]-1,3,4-oxadiazol-2-yl}phenol
SMILES (canonical)	CC(C)(C)C1=CC=C(CCC2=NN=C(O2)C2=CC=C(O)C=C2)C=C1
Molecular Formula	C20H22N2O2
Molecular Weight (g/mol)	322.408
InChl	InChI=1S/C20H22N2O2/c1-20(2,3)16-9-4-14(5-10-16)6-13-18-21-22-19(24-18)15-7-11-17(23)12-8-15/h4-5,7-12,23H,6,13H2,1-3H3
Structural Information
Clinical Information
Biological Information
Secondary Indication	Chikungunya virus (CHIKV) NA 899
Secondary Indication (Approaches)	Experimental
Secondary Indication (Methods)	In-vitro
Secondary Indication (Model system) [cell lines/ animal models]	Vero
Secondary Indication (Mode of viral infection)	Adsorption
Secondary Indication (Viral titer)	0.01 MOI
Secondary Indication (Mode of drug delivery)	Culture
Secondary Indication (Time of drug delivery)	Post infection
Secondary Indication (Duration of drug delivery)	5 days
Secondary Indication (Drug concentration)	108 ± 31.7 μM
Secondary Indication (Cell based assay)	CPE reduction assay
Secondary Indication (Change)	Decrease
Secondary Indication (Type of Inhibition)	IC50 [ 50 % ]
Secondary Indication (Cytotoxicity)	191 ± 47.1 μM
Reference	Giancotti G, Cancellieri M, Balboni A, Giustiniano M, Novellino E, Delang L, Neyts J, Leyssen P, Brancale A, Bassetto M..Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against Chikungunya virus..Eur J Med Chem. 2018 Apr 10;149:56-68. doi: 10.1016/j.ejmech.2018.02.054. Epub 2018 Feb 23. PMID:29499487
Comment	NA